Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 1181–1200 of 17,529 recalls

May 24, 2024· SYNCHRONICITY SPA INC, DBA SUNTE

Recalled Item: suntegrity

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 24, 2024· SYNCHRONICITY SPA INC, DBA SUNTE

Recalled Item: suntegrity

The Issue: Microbial Contamination of Non-Sterile Products: Presence of Aspergillus

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
May 23, 2024· Eugia US LLC

Recalled Item: Dexamethasone Sodium Phosphate injection USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 23, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Zoledronic Acid Injection 5mg/100mL Sterile Solution

The Issue: Lack of Assurance of Sterility: Leaking vials

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 22, 2024· MexHealth LLC

Recalled Item: OSSOS-SANS con: Glucosamina Curcuma Ortiga tablets

The Issue: Undeclared Diclofenac

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 22, 2024· Eugia US LLC

Recalled Item: Eptifibatide injection 20mg/10mL (2mg/mL)

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 20, 2024· Genentech, Inc.

Recalled Item: Cathflo activase (ALTEPLASE)

The Issue: Lack of Assurance of Sterility: Deformed stoppers observed

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 20, 2024· Pfizer Inc.

Recalled Item: Labetalol Hydrochloride Injection

The Issue: Lack of Assurance of Sterility-The potential for incomplete

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 20, 2024· Pfizer Inc.

Recalled Item: Buprenorphine Hydrochloride Injection

The Issue: Lack of Assurance of Sterility-The potential for incomplete

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 20, 2024· Contract Pharmacal Corporation

Recalled Item: Extra Strength Acetaminophen 500 MG Tablets

The Issue: Discoloration: Brownish tablets

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 17, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
May 17, 2024· GlaxoSmithKline LLC

Recalled Item: Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension

The Issue: Labeling: Incorrect Lot and/or Expiration Date: The carton

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
May 16, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Estradiol Transdermal System

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 16, 2024· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Estradiol Transdermal System

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 16, 2024· Rising Pharma Holding, Inc.

Recalled Item: Pregabalin Capsules 50mg

The Issue: Presence of Foreign Tablets/Capsules: Complaint received from a

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 15, 2024· Regeneron Pharmaceuticals Inc

Recalled Item: EYLEA

The Issue: Lack of Assurance of Sterility: Complaints of syringe

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1%...

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund